chr15-48505069-C-G
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PS1PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000138.5(FBN1):c.1916G>C(p.Cys639Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C639Y) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.1916G>C | p.Cys639Ser | missense_variant | 16/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.1916G>C | p.Cys639Ser | missense_variant | 15/65 | NP_001393645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.1916G>C | p.Cys639Ser | missense_variant | 16/66 | 1 | NM_000138.5 | ENSP00000325527 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 24, 2016 | Variant Summary: The FBN1 c.1916G>C (p.Cys639Ser) variant involves a conserved nucleotide and lies in a conserved region within EGF-like #6 domain of the FBN1 protein. Alteration of cysteine in this domain is likely to disrupt disulfide binding, thus affecting secondary or tertiary structure of the protein or possibly impairing fibrillin interactions. In support of the deleterious effect of this variant, 5/5 in silico analyses predict a disease-causing/damaging outcome and the variant is absent in control population from ExAC (0/121408 chromosomes). In addition, another variant at the same codon c.1916G>A (p.Cys639Trp) has been identified in at least 5 patients presenting with either isolated EL or classical MFS (Li, 2014; Howarth, 2007; Robinson, 2012). Lastly, the variant was identified in an internal sample referred for genetic testing due to personal and FH that is highly specific for disease associated with alteration of FBN1 gene. By applying ACMG rules (PM1, PM2, PM5, PP3, PP4), the variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at